A single-center experience in the management of head and neck lymphangiomas.

Paolo Aluffi VallettiMatteo BrucoliPaolo BoffanoArnaldo BenechAndrea TosoValeria Dell'EraMassimiliano Garzaro

Published in: Oral and maxillofacial surgery (2020)

All modes of treatment are important in properly selected patients affected by lymphangiomas. OK-432 therapy is a safe and effective option in the treatment of head and neck lymphangiomas.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
combination therapy
stem cells
prognostic factors
bone marrow
smoking cessation
cell therapy